x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > Avoiding Malnutrition and Cachexia to Improve Patient Outcomes
Print

Avoiding Malnutrition and Cachexia to Improve Patient Outcomes

12.11.2021  -  13.11.2021

Online

Description

Chairs 

J. Arends, DE - M. Muscaritoli, IT

Foreword

Malnutrition seriously impacts on clinical outcome in surgical and medical cancer patients. Prevention and early recognition and treatment are essential and require regular screening and professional assessment to detect relevant derangements limiting food intake, physical activity and anabolic potential. The pathophysiology of events is being increasingly understood and to improve optimal nutritional support appropriately tailored multiprofessional interventions are recommended. This refers to all settings of cancer care including pre-surgical prehabilitation, parallel support during radiation therapy and systemic anticancer treatment, as well as post-treatment rehabilitation. To enable cancer centers to offer these complex guideline-supported interventions, setting aside and guiding appropriate healthcare resources is essential and requires further emphasis.

Learning objectives

  • To understand the pathophysiology and impact of malnutrition on clinical outcome and discern different options to detect and fight major causes of malnutrition, sarcopenia and cachexia
  • To understand the differences between malnutrition, cachexia and sarcopenia and how they are imbricated and differentially diagnosed in cancer patients
  • To learn from case discussions how to best implement nutrition assessment and choosing nutritional interventions
  • To discuss essential reimbursement issues of nutritional therapy and the challenges of appropriately distributing required health care resources

Conference format

The conference will be held online and free of charge, via OncoCorner platform.

Conference content

The event will consist of:

    1. On demand material

  • recorded presentations by Experts, made available on the OncoCorner platform two weeks before the start of the virtual event;
  • four recorded patient cases, made available on the OncoCorner platform one week before the start of the virtual event;

    2. Consecutive 2-day live sessions

During the live streaming of the event (12/13 November 2021) live and pre-recorded sessions will be webcasted and participants will be able to discuss the topics with the involved experts via chat.

All the content will be recorded and will remain accessible via the OncoCorner platform until November 2022 (registration to access the contents will remain open).

Programme

12 November

 Prehabilitation in surgical and medical oncology; impact of sarcopenia/cachexia on treatment
 14:30Welcome and introduction
Jann Arends, DE - Maurizio Muscaritoli, IT
 14:35Summary of prerecorded lectures with take-home messages
Nicole Erickson, DE - Stefan Gijssels, BE - Jane B. Hopkinson, UK - Alessio Molfino, IT - Florian Strasser, CH
 14:45Q&A
Jann Arends, DE - Nicole Erickson, DE - Stefan Gijssels, BE - Jane B. Hopkinson, UK - Alessio Molfino, IT - Maurizio Muscaritoli, IT - Florian Strasser, CH
 14:55Impact of malnutrition and need for prehabilitation and post-surgical nutritional care
Arved Weimann, DE
 15:05Q&A
Jann Arends, DE - Maurizio Muscaritoli, IT - Arved Weimann, DE
 15:10Impact of malnutrition on drug treatment toxicity and efficacy
Vickie Baracos, CA
 15:20Q&A
Jann Arends, DE - Vickie Baracos, CA - Maurizio Muscaritoli, IT
 15:25Patient case A: live introduction and discussion
Elisabeth Hütterer, AT
 15:35Patient case B: live introduction and discussion
François Goldwasser, FR
 15:45Q&A about patient cases A and B
Jann Arends, DE - François Goldwasser, FR - Elisabeth Hütterer, AT - Maurizio Muscaritoli, IT
 15:50Closing remarks
Jann Arends, DE - Maurizio Muscaritoli, IT

13 November

 Early detection and practical guidance for malnutrition management; impact of sarcopenia/cachexia on drug therapy
 14:30Welcome and introduction
Jann Arends, DE - Maurizio Muscaritoli, IT
 14:35Summary of prerecorded lectures with take-home messages
Rocco Barazzoni, IT - Egidio G. Del Fabbro, US - Liat Deutsch, IL - Virpi Sulosaari, FI - Jean-Jacques Zambrowski, FR
 14:45Q&A
Jann Arends, DE - Rocco Barazzoni, IT - Egidio G. Del Fabbro, US - Liat Deutsch, IL - Maurizio Muscaritoli, IT - Virpi Sulosaari, FI - Jean-Jacques Zambrowski, FR
 14:55Practical means for nutrition screening and assessment
Nicole Erickson, DE
 15:05Q&A
Jann Arends, DE - Nicole Erickson, DE - Maurizio Muscaritoli, IT
 15:10Reimbursement of nutritional therapies: a way to equal access to care
Jean-Jacques Zambrowski, FR
 15:20Q&A
Jann Arends, DE - Maurizio Muscaritoli, IT - Jean-Jacques Zambrowski, FR
 15:25Patient case C: live introduction and discussion
Alessandro Laviano, IT
 15:35Patient case D: live introduction and discussion
Virpi Sulosaari, FI
 15:45Q&A about patient cases C and D
Jann Arends, DE - Alessandro Laviano, IT - Maurizio Muscaritoli, IT - Virpi Sulosaari, FI
 15:50Closing remarks
Jann Arends, DE - Maurizio Muscaritoli, IT

General information

ORGANISING SECRETARIAT

Sharing Progress in Cancer Care
Piazza Indipendenza, 2
6500 Bellinzona – Switzerland

Annalisa Musco
annalisa.musco@spcc.net - Tel: +39 331 6832686

CME Accreditation and Certificates
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). Information on the status of the application can be obtained from the organising secretariat.
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.

ACKNOWLEDGEMENTS
Sharing Progress in Cancer Care wishes to extend its appreciation to Fresenius Kabi and Helsinn Healthcare SA for having granted their participation and support to the Conference.

Faculty

INVITED FACULTY
Jann Arends, University of Freiburg, Department of Medicine I, Medical Center, Freiburg, DE
Vickie Baracos, University of Alberta, Department of Oncology, Edmonton, CA
Rocco Barazzoni, University of Trieste, Department of Medical Sciences, Trieste, IT
Jacqueline Bowman, European Association for the Study of Obesity (EASO), Brussels, BE
Egidio G. Del Fabbro, Chair of the Nutrition and Cachexia Study Group, MASCC and Virginia Commonwealth University Health System, Richmond, US
Liat Deutsch, Tel-Aviv Sourasky Medical Center, The Institute of Gastroenterology and Liver diseases, Tel Aviv, IL
Nicole Erickson, Comprehensive Cancer Center, University Hospital, LMU Munich, Munich, Germany, DE
Stefan Gijssels, Patient Expert, Overijse, BE
François Goldwasser, Medical Oncology Department, Cochin Port Royal Hospital, Laboratory URP 4466, Paris University, FR
Jane B. Hopkinson, Cardiff University, School of Healthcare Sciences, Cardiff, UK
Elisabeth Hütterer, Division of Oncology, Department of Medicine I, Medical University of Vienna, AU
Alessandro Laviano, Sapienza Università di Roma, Department of Translational and Precision Medicine, Roma, IT
Alessio Molfino, Sapienza Università di Roma, Department of Translational and Precision Medicine, Roma, IT
Maurizio Muscaritoli, Sapienza Università di Roma, Department of Translational and Precision Medicine, Rome, IT
Florian Strasser, Cancer Fatigue Clinic at Onkologie-Schaffhausen and Cantonal Hospital, St. Gallen, CH
Virpi Sulosaari, European Oncology Nursing Society (EONS) and Turku University of Applied Sciences, Turku, FI
Ariane Vander Stappen, European Commission, DG SANTE - Unit E1 - Food information and composition, Brussels, BE
Arved Weimann, St. George Hospital, Department for General and Visceral Surgery and Clinical Nutrition, Leipzig, DE
Jean-Jacques Zambrowski, Health Policies & Health Economics, Université Paris-Saclay, Paris, FR